about
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral functionRNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesisNeural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication.Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.Increased SP4 and SP1 transcription factor expression in the postmortem hippocampus of chronic schizophrenia.Chronic treatment with the opioid antagonist naltrexone favours the coupling of spinal cord μ-opioid receptors to Gαz protein subunits.TGF-β and opioid receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under pathological pain conditions.Muscarinic receptor changes in the gerbil thalamus during aging.Differential effects on [35S]GTPgammaS binding using muscarinic agonists and antagonists in the gerbil brain.The absence of 5-HT4 receptors modulates depression- and anxiety-like responses and influences the response of fluoxetine in olfactory bulbectomised mice: Adaptive changes in hippocampal neuroplasticity markers and 5-HT1A autoreceptor.Enhanced Stress Response in 5-HT1AR Overexpressing Mice: Altered HPA Function and Hippocampal Long-Term Potentiation.Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5-HT/glutamate neurotransmission: role of 5-HT1A receptors.Pharmacological characterization and autoradiographic distribution of alpha2-adrenoceptor antagonist [3H]RX 821002 binding sites in the chicken brain.Cannabinoid system in the budgerigar brain.Modulation of neuroplasticity pathways and antidepressant-like behavioural responses following the short-term (3 and 7 days) administration of the 5-HT₄ receptor agonist RS67333.Targeting β-Catenin in GLAST-Expressing Cells: Impact on Anxiety and Depression-Related Behavior and Hippocampal Proliferationβ-Catenin Role in the Vulnerability/Resilience to Stress-Related Disorders Is Associated to Changes in the Serotonergic System
P50
Q24594672-CF004ECF-7573-4778-86FF-BE49790E204BQ36593806-0F54C55F-84A5-43E6-B93D-94D58B1B51C2Q38122158-68B24B4E-5BC7-485C-97C0-14160AD78D83Q38552025-CC115BED-2316-4066-BFC7-92898B2286E4Q41881371-FA6472AD-7103-4A60-89CA-D7D4C12CAECBQ44180870-614DF26B-36C6-4D3A-AFE1-19D354358EE4Q44330547-DB7C2F51-A8B7-479A-B783-E8597DB1BDAFQ44344407-83DE8C3A-2CDC-4600-ACE4-12A07822BDCFQ44884513-FF170B87-D496-4302-A8FC-4329CFD4EC48Q46646442-F94B0B95-C823-4A94-8127-4AF8174EC5ECQ47396236-4813BE49-9BE8-406C-A770-ADA05FC058D1Q47654007-97082A08-2C31-40A5-8CFF-2E2D776EF541Q47889899-3F84E7EB-D21C-40D1-8D84-75617874614EQ48542203-FF43C991-619F-420C-8D69-D24D6EA870ECQ48576596-05CCA25A-77E0-44DD-8746-D1C9C56DE970Q49083734-560FA4A5-78DB-484F-9589-34E5C5975DCAQ63455505-9D6850BE-A26B-4189-A2D1-718FD70183C5Q91858699-A2CF34A5-3F32-45AB-BC3F-115E7236D979
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fuencisla Pilar-Cuellar
@ast
Fuencisla Pilar-Cuellar
@en
Fuencisla Pilar-Cuellar
@es
Fuencisla Pilar-Cuellar
@nl
Fuencisla Pilar-Cuellar
@sl
type
label
Fuencisla Pilar-Cuellar
@ast
Fuencisla Pilar-Cuellar
@en
Fuencisla Pilar-Cuellar
@es
Fuencisla Pilar-Cuellar
@nl
Fuencisla Pilar-Cuellar
@sl
prefLabel
Fuencisla Pilar-Cuellar
@ast
Fuencisla Pilar-Cuellar
@en
Fuencisla Pilar-Cuellar
@es
Fuencisla Pilar-Cuellar
@nl
Fuencisla Pilar-Cuellar
@sl
P1053
L-2983-2014
P106
P1153
8865610600
P21
P31
P3829
P496
0000-0003-1229-001X